Skip to content
2000
Volume 2, Issue 1
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Sabarubicin (MEN 10755) is the progenitor of a third generation of synthetic anthracycline oligosaccharides. Sabarubicin deamino analogues MEN 10959 and MEN 12297 were evaluated for topoisomerase II poisoning, cytotoxic potency and antitumor activity in human xenografts. The new analogues were able to induce DNA cleavage mediated by both DNA topoisomerase IIα and β and a good correlation was found regarding their cytotoxic activity. The two analogues possess also a different spectrum of antitumor activity, compared to sabarubicin.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180053398307
2005-02-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180053398307
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test